Biodesix to report first quarter 2022 financial results on may 11, 2022

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will release financial results for the first quarter ended march 31, 2022 before the open of trading on wednesday, may 11. biodesix's management will host a conference call and webcast to discuss its financial results and provide a general business update at 8:00 a.m. eastern time on the same day. dial-in and call details are as
BDSX Ratings Summary
BDSX Quant Ranking